Skip to main content
رجوع
AMN logo

AMN Healthcare Services, Inc.

جودة البيانات: 100%
AMN
NYSE Healthcare Medical - Care Facilities
KWD 18.49
▲ KWD 0.10 (0.54%)
القيمة السوقية: 714.47M
نطاق اليوم
KWD 18.09 KWD 18.84
نطاق 52 أسبوعًا
KWD 14.87 KWD 24.89
حجم التداول
533,230
متوسط 50 يوم / 200 يوم
KWD 19.33 / KWD 19.03
الإغلاق السابق
KWD 18.39

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E -7.5 0.3
P/B 1.1 2.9
ROE % -14.2 3.7
Net Margin % -3.5 3.8
Rev Growth 5Y % -9.0 10.0
D/E 1.3 0.2

السعر المستهدف للمحللين

Hold
KWD 22.880 +23.7%
Low: KWD 19.500 High: KWD 25.000
مكرر الربحية المستقبلي
9.0
ربحية السهم المستقبلية
KWD 2.035
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
3.2 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2028 KWD 1.069
KWD 1.058 – KWD 1.092
2.8 B 1
FY2027 KWD 1.120
KWD 1.000 – KWD 1.280
2.7 B 5
FY2026 KWD 2.035
KWD 1.588 – KWD 2.263
3.2 B 6

Insider Trading Activity

11 transactions
Date Insider Type Shares Price Value
Jan 15, 2026
Grace Caroline
Chief Executive Officer
other 92,661
Jan 15, 2026
Grace Caroline
Chief Executive Officer
grant 129,923
Jan 15, 2026
Hagan Mark Christopher
Chief Information and Digital
other 49,530
Jan 15, 2026
Hagan Mark Christopher
Chief Information and Digital
grant 73,656
Jan 15, 2026
Laughlin Whitney M
Chief Legal Officer
other 20,616
Jan 15, 2026
Laughlin Whitney M
Chief Legal Officer
grant 39,282
Jan 15, 2026
Scott Brian M.
CFO/COO
other 30,121
Jan 15, 2026
Scott Brian M.
CFO/COO
grant 40,920
May 2, 2025
Jones Daphne E
Director
grant 8,325
May 2, 2025
Trent-Adams Sylvia
Director
grant 8,325
Apr 19, 2025
Trent-Adams Sylvia
Director
other 6,038

النقاط الرئيسية

Revenue declined -9.01% annually over 5 years
Generating 233.83M in free cash flow
PEG of 0.18 suggests growth is underpriced
Capital efficient — spends only 1.30% of revenue on capex
ROIC of 1.72% — low return on invested capital
Interest coverage of 0.73× — tight debt servicing

النمو

Revenue Growth (5Y)
-9.01%
Revenue (1Y)-8.49%
Earnings (1Y)N/A
FCF Growth (3Y)-6.38%

الجودة

Return on Equity
-14.19%
ROIC1.72%
Net Margin-3.51%
Op. Margin1.21%

الأمان

Debt / Equity
1.25
Current Ratio0.94
Interest Coverage0.73

التقييم

P/E Ratio
-7.47
P/B Ratio1.11
EV/EBITDA44.73
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -8.49% Revenue Growth (3Y) -15.11%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -9.01% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2.73B Net Income (TTM) -95.70M
ROE -14.19% ROA -4.57%
Gross Margin 22.93% Operating Margin 1.21%
Net Margin -3.51% Free Cash Flow (TTM) 233.83M
ROIC 1.72% FCF Growth (3Y) -6.38%
Safety
Debt / Equity 1.25 Current Ratio 0.94
Interest Coverage 0.73 Dividend Yield 0.00%
Valuation
P/E Ratio -7.47 P/B Ratio 1.11
P/S Ratio 0.26 PEG Ratio 0.18
EV/EBITDA 44.73 Dividend Yield 0.00%
Market Cap 714.47M Enterprise Value 1.48B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2.73B 2.98B 3.79B 5.24B 3.98B
Net Income -95.70M -146.98M 210.68M 444.05M 327.39M
EPS (Diluted) -2.48 -3.85 5.36 9.90 6.81
Gross Profit 626.19M 919.38M 1.25B 1.72B 1.31B
Operating Income 33.17M -102.67M 338.43M 647.10M 478.00M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2.09B 2.42B 2.92B 2.89B 3.13B
Total Liabilities 1.45B 1.71B 2.09B 1.84B 1.97B
Shareholders' Equity 642.11M 706.62M 831.26M 1.04B 1.16B
Total Debt 803.20M 1.10B 1.35B 860.96M 867.07M
Cash & Equivalents 33.97M 10.65M 32.94M 64.52M 180.93M
Current Assets 545.38M 594.92M 841.69M 1.09B 1.35B
Current Liabilities 577.61M 545.79M 656.12M 857.93M 969.39M